 
                         
                         
                         
                    
                    PELMIC TABLET
                            COMPOSITION DICLOFENAC POTASSIUM 50 MG + SERRATIOPEPTIDASE 10 MG MRP 675.00 PACKING SIZE 10 X 10 (ALU-ALU) PACKING TYPE BOX FORM TABLET GST  5% GRADE STANDARD MEDICINE 
DESCRIPTION
Pelmic Tablet (Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg) is a combination medication used to relieve pain and inflammation. Diclofenac is an NSAID that reduces pain and swelling, while Serratiopeptidase is an enzyme that helps break down proteins and reduces inflammation. This combination is commonly used for conditions like arthritis, muscle pain, and post-surgical inflammation. It is usually taken orally, with or after food to minimize stomach irritation.
INDICATION
Rheumatoid Arthritis : Rheumatoid joint pain is a restorative condition that causes torment, swelling, firmness and misfortune of work in the little joints of your body. The indications incorporate joint torment, solidness and delicacy. In a few cases, the condition can harm other organs counting the skin, eyes, lungs, heart and blood vessels. Pelmic Tablet (Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg) decreases torment and swelling related with such conditions.





 
MECHANISM OF ACTION
Diclofenac potassium is a nonsteroidal anti-inflammatory sedate (NSAID) that basically represses cyclooxygenase (COX) chemicals, particularly COX-2. COX chemicals are included in the generation of prostaglandins, which are chemicals that advance irritation, torment, and fever. By repressing COX-2, diclofenac potassium diminishes the amalgamation of prostaglandins, in this manner reducing aggravation, diminishing torment, and bringing down fever. Its potassium salt frame permits for quicker assimilation and onset of activity compared to other shapes.
Serratiopeptidase offers a few benefits through its components of activity. It applies an anti-inflammatory impact by processing provocative go betweens, dead tissue, and cellular flotsam and jetsam, which makes a difference to decrease swelling and aggravation. Also, it has an pain relieving impact by bringing down the concentration of pain-causing substances and encouraging the breakdown of provocative proteins, in this way giving assist torment alleviation. Its fibrinolytic impact includes dissolving fibrin, a protein included in blood clotting, which makes a difference to diminish tissue edema and improve nearby circulation.
 
DRUG INTERACTIONS
Drug-Drug Interaction : Pelmic Tablet (Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg) may associated with painkillers (nimesulide, oxyphenbutazone, metamizole), anti-cancer (methotrexate), lithium, iodine, and blood clotting operators (warfarin).
Drug-Food Interaction : Drinking liquor ought to be dodged whereas taking Pelmic Tablet as it can cause obnoxious effects.
Drug-Disease Interaction : Individuals with peptic ulcer, gastric dying, serious heart disappointment, stroke, ulcerative colitis, Crohn's infection, liquor abuse, and tall blood weight ought to maintain a strategic distance from admissions of Pelmic Tablet.
SIDE EFFECT OF PELMIC TABLET
Major & minor side effects for Pelmic Tablet
 
PRECAUTIONS
When utilizing a combination of Pelmic Tablet (Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg) it's pivotal to be mindful of a few safety measures. Diclofenac can cause gastrointestinal issues such as ulcers and dying, affect kidney work, and hoist cardiovascular hazard, particularly with long-term utilize. It ought to be taken with nourishment to diminish stomach bothering and checked frequently for potential side impacts. Serratiopeptidase, on the other hand, may increment dying chance and might associated with other solutions, especially anticoagulants. Both drugs require caution amid pregnancy and breastfeeding, with constrained security information accessible. Continuously counsel your healthcare supplier some time recently beginning this combination, follow entirely to endorsed doses, and screen for any unfavorable impacts or intelligent.
 
DISCLAIMER
The information on this website is provided for general informational purposes only and is not medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Consult a qualified healthcare provider for personalized advice. We do not endorse any specific products, treatments, or services mentioned.
Jantec Pharma is a leading Diclofenac Potassium 50 mg & Serratiopeptidase 10 mg manufacturer and supplier, committed to delivering effective and high-quality medicines. With WHO-GMP certified production facilities and over 25 years of industry expertise, we ensure every formulation meets global standards. Our partners benefit from trusted product quality, attractive packaging, and efficient logistics across India.
As a recognized Diclofenac Potassium 50 mg & Serratiopeptidase 10 mg manufacturer and supplier in India, Jantec Pharma also provides third-party manufacturing solutions. Headquartered in Delhi, we maintain a strong distribution network that ensures timely delivery and reliable services nationwide.
Jantec Pharma invites business aspirants to join its Diclofenac Potassium 50 mg & Serratiopeptidase 10 mg PCD Pharma franchise program. With monopoly rights, promotional materials, and WHO-GMP certified products, we offer complete support for business success. Our 25+ years of trust and diverse portfolio make us one of the most reliable names in pharmaceuticals.
By choosing our Diclofenac Potassium 50 mg & Serratiopeptidase 10 mg PCD Pharma franchise in India, you gain a stable and profitable business opportunity. With Diclofenac Potassium 50 mg & Serratiopeptidase 10 mg PCD Pharma franchise, we ensure consistent growth, strong brand support, and long-term partnerships.
Just one more step!
Login first,to proceed further.
 
            Please provide your contact information:
Our team will reach out to you soon.
Our team will reach out to you soon.
© 2025 Jantec Pharma All Rights Reserve | Privacy Policy